Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
9.21
+0.03 (0.33%)
At close: Dec 5, 2025, 4:00 PM EST
9.40
+0.19 (2.03%)
After-hours: Dec 5, 2025, 7:02 PM EST
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $29.28 million as of December 5, 2025. Its market cap has decreased by -1.67% in one year.
Market Cap
29.28M
Enterprise Value
839.92K
1-Year Change
-1.67%
Ranking
Category
Stock Price
$9.21
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $29.28M, a decrease of -96.94%. That is a compound annual growth rate of -45.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 29.28M | -16.42% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |